Medico Remedies Ltd - 540937 - Board Meeting Intimation for Notice Of The Board Meeting
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2023 ,inter alia, to consider and approve 1. Audited Financial Results for the half year ended 31st March, 2023 and Audited Financial Statements for the year ended on 31st March, 2023 Medico Remedies Ltd - 540937 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMedico Remedies Ltd 2CIN NO.L24230MH1994PLC077187 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.25 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: DINESH MODI Designation: COMPANY SECRETARY EmailId: secretarialmrl@gmail.com Name of the Chief Financial Officer: HARESH MEHTA Designation: CHAIRMAN AND WTD CFO EmailId: hareshmehta1955@gmail.com Date: 29/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Medico Remedies Ltd - 540937 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMedico Remedies Ltd 2CIN NO.L24230MH1994PLC077187 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.25 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: DINESH NAVNITLAL MODI Designation: COMPANY SECRETARY EmailId: secretarialmrl@gmail.com Name of the Chief Financial Officer: HARESH KAPURLAL MEHTA Designation: CHAIRMAN AND WTD CFO EmailId: HARESHMEHTA1955@gmail.com Date: 24/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Medico Remedies Ltd - 540937 - Compliance Certificate For The Year Ended On 31St March, 2023 Pursuant To Regulation 7(3) Of The SEBI (LODR) Regulations, 2015
We hereby submit the duly signed Compliance Certificate for the year ended on 31st March, 2023 pursuant to Regulation 7(3) of the SEBI (LODR) Regulations, 2015. Medico Remedies Ltd - 540937 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2023
We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended 31st March, 2023. Medico Remedies Ltd - 540937 - Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended & Company''s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in its securities, the ''Trading Window'' for dealing in the equity shares of the Company is closed, for all Insiders, Designated Persons and their immediate relatives, from 1st April, 2023 up to the expiry of 48 hours post the date of declaration of the Audited Financial Results for the year ended 31st March, 2023 Medico Remedies Ltd - 540937 - Corporate Action-Updates on intimation of Sub division / Stock Split
This is in continuation to our communication dated 04th March, 2023 with respect to Sub-Division of Equity Share fully paid up with effect from March 16, 2023(Record Date). Please be informed that the Sub- Division of Equity Shares will take effect under the new ISIN i.e. INE630Y01024. Medico Remedies Ltd - 540937 - Intimation Of Record Date For Sub-Division/Split Of Equity Shares
With reference to the above cited subject, we would like to inform to the exchange that Board of the Directors of the Company have fixed Thursday, 16th March, 2023 as the 'Record Date' for ascertaining eligibility of shareholders entitled for corporate action of - 1. Sub-division/split of 1 (One) equity shares of face value Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) equity shares of Rs. 2/- (Rupees Two Only) each fully paid up. Medico Remedies Ltd - 540937 - Disclosure On E-Voting Results On Resolutions Passed Through Postal Ballot By Medico Remedies Limited ('The Company')
In furtherance to our communication dated 2nd February, 2023 in connection with the Postal Ballot conducted by the Company for seeking approval of the Shareholders for matters set out in the Notice of Postal Ballot dated 2nd February, 2023 and pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the following: 1. Voting Results as required pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 marked as Annexure-I; and 2. Scrutinizers' Report on e-Voting Results on resolutions passed through Postal Ballot marked as Annexure-II The said resolutions as set out in Postal Ballot Notice are passed with the requisite majority and is deemed to be passed on the last date of the e-voting, i.e. 4th March, 2023. Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper advertisements published in 'Active Times' (English Edition) and in 'Mumbai Lakshadeep' (Marathi Edition) on 12th February, 2023 for announcement of Unaudited Standalone Financial Results for the Quarter and Nine Months ended 31st December, 2022.